Susquehanna International Group, LLP Yumanity Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.5 - $1.87 $3,712 - $4,628	2,475 Added 12.33%	22,556 $35,000
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.99 $8,511 - $16,606	-8,345 Reduced 29.36%	20,081 $37,000
Q1 2022 May 16, 2022	BUY	$0.97 - $3.27 $11,879 - $40,047	12,247 Added 75.7%	28,426 $43,000
Q4 2021 Feb 14, 2022	SELL	$2.81 - $10.48 $70,854 - $264,253	-25,215 Reduced 60.91%	16,179 $48,000
Q3 2021 Nov 15, 2021	BUY	$8.3 - $12.04 $343,570 - $498,383	41,394 New	41,394 $427,000

Q2 2021 Aug 11, 2021	SELL	$11.27 - $19.64 $175,541 - $305,912	-15,576 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.69 - $22.52 $259,963 - $350,771	15,576 New	15,576 $282,000

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.